These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9043854)

  • 21. Use of prostacyclin and its analogues in the treatment of cardiovascular disease.
    Fink AN; Frishman WH; Azizad M; Agarwal Y
    Heart Dis; 1999; 1(1):29-40. PubMed ID: 11720602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostacyclin offers protection against early extension of acute myocardial infarction.
    Henriksson P; Edhag O; Wennmalm A
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():435-6. PubMed ID: 2959092
    [No Abstract]   [Full Text] [Related]  

  • 23. [Thrombocyte aggregation inhibitors, anticoagulants and thrombolytic agents in heart diseases].
    Darius H; Erbel R; Belz GG; Meyer J
    Internist (Berl); 1992 Oct; 33(10):670-83. PubMed ID: 1428685
    [No Abstract]   [Full Text] [Related]  

  • 24. Intracoronarily administered prostacyclin and streptokinase for treatment of myocardial infarction.
    Blaskó G; Berentey E; Harsányi A; Sas G
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():385-90. PubMed ID: 6221550
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostacyclin infusion in patients with acute myocardial infarction.
    Henriksson P; Edhag O; Wennmalm A
    Br Heart J; 1985 Feb; 53(2):173-9. PubMed ID: 2857087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilot study of the effects of taprostene (CG 4203) in patients with advanced peripheral arterial disease.
    Darius H; Kopp H; Mulfinger A; Spielberger M; Todt M; Schuster CJ; Meyer J
    Prog Clin Biol Res; 1989; 301():417-21. PubMed ID: 2508112
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prostacyclin therapy of peripheral artery disease].
    Kusaba A
    Kokyu To Junkan; 1985 Jul; 33(7):871-6. PubMed ID: 3903902
    [No Abstract]   [Full Text] [Related]  

  • 29. A single center, open, randomized study investigating the clinical safety and the endothelial modulating effects of a prostacyclin analog in combination with eptifibatide in patients having undergone primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction.
    Holmvang L; Ostrowski SR; Dridi NP; Johansson P
    Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):87-95. PubMed ID: 22951358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of low concentrations of prostacyclin on platelet function in vitro.
    van Heerden PV; Gibbs NM; Michalopoulos N
    Anaesth Intensive Care; 1997 Aug; 25(4):343-6. PubMed ID: 9288373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epoprostenol in chronic thromboembolic pulmonary hypertension with distal lesions.
    Scelsi L; Ghio S; Campana C; D'Armini AM; Serio A; Klersy C; Piovella F; Viganò M; Tavazzi L
    Ital Heart J; 2004 Aug; 5(8):618-23. PubMed ID: 15554033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct].
    Di Pasquale G; Ottani F; Ceré E; Biancoli S; Sassone B; Lombardi A
    Recenti Prog Med; 1998 Oct; 89(10):514-9. PubMed ID: 9842255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
    Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714
    [No Abstract]   [Full Text] [Related]  

  • 34. [Platelet inhibitors or anticoagulants in prevention after myocardial infarct? The 1991 state of the art].
    van de Loo J; Kienast J
    Z Gesamte Inn Med; 1992 Jan; 47(1):1-5. PubMed ID: 1570716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Spleen rupture in myocardial infarction after administration of GP IIb-IIIa-antagonists].
    Feldmann C; Deutsch HJ
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):29-30. PubMed ID: 15619171
    [No Abstract]   [Full Text] [Related]  

  • 36. Epoprostenol for primary pulmonary hypertension.
    Med Lett Drugs Ther; 1996 Feb; 38(968):14-5. PubMed ID: 8592477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prostacyclin--its function and indications for therapeutic use].
    Ram R; Levy Y; Shoenfeld Y
    Harefuah; 2000 Jan; 138(1):54-8. PubMed ID: 10868182
    [No Abstract]   [Full Text] [Related]  

  • 38. Prostacyclin: a vascular mediator.
    Vane J; Corin RE
    Eur J Vasc Endovasc Surg; 2003 Dec; 26(6):571-8. PubMed ID: 14603414
    [No Abstract]   [Full Text] [Related]  

  • 39. [Gastrointestinal bleeding in a patient with acute myocardial infarction treated with primary coronary angioplasty and abciximab (ReoPro) administration].
    Gziut AI; Pastwa Ł; Słysz A
    Kardiol Pol; 2006 Mar; 64(3):334-6; discussion 337-8. PubMed ID: 16583343
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of oral prostacyclin on microclots in tube lines of a hemodialysis system.
    Ozasa H; Suzuki T; Ota K
    Nephron; 1995; 71(1):106-7. PubMed ID: 8538831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.